Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

169 in total

Review 1. Metastatic breast cancer: The Odyssey of personalization.

Authors: A Sonnenblick; N Pondé; M Piccart
Journal: Mol Oncol Date: 2016-07-11 Impact factor: 6.603

2. P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.

Authors: André Filipe Vieira; Maria Rita Dionísio; Madalena Gomes; Jorge F Cameselle-Teijeiro; Manuela Lacerda; Isabel Amendoeira; Fernando Schmitt; Joana Paredes
Journal: Mod Pathol Date: 2017-01-13 Impact factor: 7.842

3. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology.

Authors: Ummugul Uyeturk; Berna Oksuzoglu; Tulay Akman; Ibrahim Turker; Nur Sener; Didem Tastekin; Oznur Bal; Veli Berk; Ulku Yalcintas Arslan; Zuhat Urakci; Cemil Bilir; Ugur Yilmaz; Dogan Yazilitas; Arife Ulas; Ozlem Uysal Sonmez; Burcin Budakoglu; Sener Cihan; Mukremin Uysal
Journal: Med Oncol Date: 2014-03-22 Impact factor: 3.064

4. A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition.

Authors: Kevin Shee; Jason D Wells; Matthew Ung; Riley A Hampsch; Nicole A Traphagen; Wei Yang; Stephanie C Liu; Megan A Zeldenrust; Liewei Wang; Krishna R Kalari; Jia Yu; Judy C Boughey; Eugene Demidenko; Arminja N Kettenbach; Chao Cheng; Matthew P Goetz; Todd W Miller
Journal: Clin Cancer Res Date: 2019-09-26 Impact factor: 12.531

5. Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis.

Authors: Jun Fan; Dali Chen; Heng Du; Cheng Shen; Guowei Che
Journal: J Thorac Dis Date: 2015-08 Impact factor: 2.895

6. N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.

Authors: Jennifer A Crozier; Pooja P Advani; Betsy LaPlant; Timothy Hobday; Anthony J Jaslowski; Alvaro Moreno-Aspitia; Edith A Perez
Journal: Clin Breast Cancer Date: 2015-08-19 Impact factor: 3.225

7. The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact.

Authors: Sadia Tasleem; Jarlath C Bolger; Michael E Kelly; Michael R Boland; Dermot Bowden; Karl J Sweeney; Carmel Malone
Journal: Ir J Med Sci Date: 2018-02-01 Impact factor: 1.568

Review 8. HER story: the next chapter in HER-2-directed therapy for advanced breast cancer.

Authors: Sunil Verma; Anil A Joy; Daniel Rayson; Deanna McLeod; Christine Brezden-Masley; Jean-François Boileau; Karen A Gelmon
Journal: Oncologist Date: 2013-11-08

Review 9. Monitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?

Authors: Marianna Alunni-Fabbroni; Volkmar Müller; Tanja Fehm; Wolfgang Janni; Brigitte Rack
Journal: Breast Care (Basel) Date: 2014-02 Impact factor: 2.860

Review 10. Trastuzumab emtansine: a review of its use in patients with HER2-positive advanced breast cancer previously treated with trastuzumab-based therapy.

Authors: Sohita Dhillon
Journal: Drugs Date: 2014-04 Impact factor: 9.546